Clinical Trial

BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry

Study acronym: BIOFLOW-VIII
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The BIOFLOW-VIII registry is a post-market clinical evaluation of the Orsiro Mission stent in subjects requiring coronary revascularization with Drug Eluting Stents (DES).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-09-17; most recent amendment 2024-06-19.
Status change: Completed → Active, Not Recruiting 2023-04-27
Status change: Recruiting → Completed 2023-02-02
Status change: Not Yet Recruiting → Recruiting 2021-08-05
Trial Details
NCT Number NCT04555174
Lead Sponsor Biotronik AG
Collaborators: Biotronik France
Conditions Coronary Artery Disease, Myocardial Ischemia
Enrollment 872 participants
Start Date 2020-09-25
Primary Completion 2023-01-18 (estimated)
Study Completion 2027-02-19 (estimated)
Updated on ClinicalTrials.gov 2024-06-21